Showing 1081-1090 of 9422 results for "".
It's Not Raining Men: The Reality of Male Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-not-raining-men-the-reality-of-male-aesthetics/20337/Before you adjust your brand to attract more men, a student of human behavior pontificates on the paucity of male cosmetic patients.Isotretinoin: Expanding Access to Improve Outcomes
https://practicaldermatology.com/topics/acne-rosacea/isotretinoin-expanding-access-to-improve-outcomes/22961/A new pharmacy service program seeks to support patient education, streamline testing, and expedite access to isotretinoin—taking responsibility off of practices.Adjusting to a Paradigm Shift in Documentation
https://practicaldermatology.com/topics/practice-management/adjusting-to-a-paradigm-shift-in-documentation/21681/Clinicians can navigate changing rules by selecting technologies that accommodate rapid shifts in documentation.What You Should Know About Antibody Testing for SARS-CoV-2
https://practicaldermatology.com/topics/infections-infectious-disease/what-you-should-know-about-antibody-testing-for-sars-cov-2/23297/Here’s what we know about testing and its potential role for practices.Overcoming Adherence Challenges in the Management of Teen Acne
https://practicaldermatology.com/topics/practice-management/overcoming-adherence-challenges-in-the-management-of-teen-acne/20591/Adherence to acne treatment regimens is notoriously low among pre-teens and adolescents. Here's how to change that.New Oral Agent May Shift Psoriasis Treatment Landscape
https://practicaldermatology.com/topics/psoriasis/new-oral-agent-may-shift-psoriasis-treatment-landscape/21258/A notable approval in 2014, apremilast may play an important role in bridging a wide gap in the care of moderate to severe psoriasis.How Do Dermatologists Handle “No-Show Appointments”?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/how-do-dermatologists-handle-no-show-appointments/20892/An online survey of dermatologists across the US is enlightening.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicImproving Dermatologic Care and Access for Gender and Sexual Minority Patients
https://practicaldermatology.com/conferences/aad-2021/improving-dermatologic-care-and-access-for-gender-and-sexual-minority-patients/19919/Dermatologists need increased knowledge of health disparities and tools to best meet the needs of sexual and gender minority patients. From increased risk of skin cancer in sexual minority individuals to acne in the transgender population, there are many dermatologic concerns arising for patients, sAbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society an